配方,优化和in-vivo表征热敏的局部鼻凝载有巴科赛德a治疗的治疗
Someshwar Dattatray Mankar1, Shraddha Ranjan Parjane2, Suhas Shivaji Siddheshwar2
1Pravara Rural College of Pharmacy, Pravaranagar, Loni (Bk), Ahmednagar, Maharashtra, 413736, India. sdmankar655@gmail.com.
AAPS PharmSciTech
|July 2, 2024
概括
这项研究开发了一种针对BACOSIDE A输送的优化热敏in-situ鼻凝,提高了生物可用性. 鼻凝配方通过减少发作的发生和强度,显示出对治疗的希望.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物输送系统 药物输送系统
- 神经科学是一个神经科学.
背景情况:
- 内鼻途径通过绕过第一通代谢,提供卓越的全身生物利用性.
- 巴科帕蒙尼耶里 (Brahmi) 传统上用于认知增强,并具有潜在的抗作用.
- 化物A是Bacopa monnieri中的主要活性化合物.
研究的目的:
- 开发和优化一种热敏的in-situ鼻凝,用于Bacoside A的输送.
- 评估鼻凝在治疗中的潜力.
主要方法:
- 为了优化配方,使用了3 ^ 2的因数设计.
- 分别使用Poloxamer 407和HPMC K4M作为热凝固剂和粘粘剂.
- 进行了ex-vivo透研究和in-vivo模型 (PTZ诱导的).
主要成果:
- 优化的配方F7显示出94.69%的活体鼻透率和30.48°C的sol-gel过渡.
- 凝温度和粘粘性强度是影响性能的关键因素.
- 优化的鼻凝在体内显著降低了发作的发生和强度.
结论:
- 优化的 in-situ 鼻凝 (F7) 是一种有前途的系统,可以通过鼻子输送 Bacoside A.
- 这种配方增强了生物可用性,并证明了治疗的潜在疗效.
更多相关视频
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
1.8K
09:11Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
Published on: February 13, 2016
9.8K
相关概念视频
Drug Delivery: Enteral Route
417
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
417
Antiepileptic Drugs: GABAergic Pathway Potentiators
382
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
382
